| 7 | Idiopathic chronic pancreatitis:Beyond antioxidants显示文摘Chronic pancreatitis(CP)is a complex disease associated with gene-gene or geneenvironment interactions.The incidence of idiopathic CP has shown an increasing trend,withits phenotypeshaving changed considerably in the last two decades.The diseaseitself can be regulated before it reaches the stage of established CP;however,the etiopathogenesis underlying idiopathic CP remains to be established,making the condition difficult to cure.Unfortunately,there also remains a lack of consensus regarding the beneficial effects of antioxidant therapiesfor CP.It is known that antioxidant therapy does not reduce inflammatory and fibrotic cytokines,making it unlikely that they could modulate the disease process.Although antioxidants are safe,very few studies to date have reported the long-term beneficial effects in patients with CP.Thus,studies are being performed to identify drugs that can improve symptoms and alter the natural history of CP.Statins,with their numerous pleiotropic effects,may play a role in the treatment of CP,butin 2006,their use was found to be associated with the undesirable side effect of promoting pancreatitis.Latter studies showed favourable effects of statins in CP,highlighting the particular benefits of lipophilic statins,such as lovastatin and simvastatin,over the hydrophilic statins,such as rosuvastatin.Ultimately,studies to repurpose N-acetylcysteine as a CP therapy areyielding very promising results. | Rajiv M Mehta Stephen J Pandol Prachi R Joshi | 2021 | World Journal of Gastroenterology2021，27，43： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员